Heliyon · 2022 · 29 citations · 32 references
Life SciencesMolecular BiologyMolecular MedicineGene ExpressionInflammationTranscriptomicsDiabetes MellitusDiabetic NeuropathyMicrorna BiologyMicrorna-mediated RegulationNoncoding Rna BiologyNoncoding Rna TranscriptomicsControl Group DesignDisease-associated MicrornasLong Non-coding Ribonucleic AcidsLong Non-coding Rna BiomarkersLung AdenocarcinomaMatched Control GroupMicrorna BiomarkersMicrorna Dysregulation In Disease
BackgroundDiabetic neuropathy (DN) is a prevalent complication of diabetes mellitus characterized by pain and inflammation. Long non-coding RNAs (lncRNAs) have been associated with DN. This study aimed to investigate transcript levels of Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1), microRNA (miR)-1-3p, and C-X-C motif chemokine receptor 4 (CXCR4) in the DN patients and type 2 diabetes mellitus (T2DM) cases without neuropathy.MethodsHere, 20 cases with DN and 20 T2DM subjects without neuropathy (as the control group) were included. Total RNA was extracted from peripheral blood mononuclear cells (PBMCs) of all participants. The expression levels of targets were evaluated by Real-time-PCR.ResultsResults showed that MALAT1 (Fold change = 2.47, P = 0.03) and CXCR4 (Fold change = 1.65, P = 0.023) were significantly upregulated, while miR-1-3p was downregulated (Fold change = 0.9, P = 0.028) in whole blood samples from DN patients compared to the control group. A significant correlation was found between transcript levels of MALAT1 and CXCR4 (rho = 0.84; P < 0.0001).ConclusionsThis study suggests a possible involvement of the MALAT1/miR-1-3p/CXCR4 axis in the pathogenesis of DN.
32
Functional microRNA targets in protein coding sequences
Martin Reczko, Manolis Maragkakis, Panagiotis Alexiou et al. · Bioinformatics · 2012 · 535 citations · Full text